Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification
Funds identifying and validating a disease target, then finding a preliminary drug, biologic or combination-product lead against it.
Before anyone can develop a therapy, something has to be identified as worth going after in the first place — a target whose biology actually explains the disease. This notice funds that identification step and the one right after it, as a single award.
It sits inside NHLBI's Catalyze Program, which exists to move basic discoveries toward diagnostic and therapeutic candidates ready for human test…
Phased target identification and validation (R61) followed by preliminary product or lead-series identification (R33) for small molecule, biologic and combination-product candidates against heart, lung, blood or sleep disease, under NHLBI's Catalyze Program.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
More from NIH
All grants from this funder →Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults
🇺🇸NIH · United States
Funds a pilot trial of a behavioural sleep intervention for adolescents and young adults who have a mental health disorder or are at risk of one.
GREGoRi Data Coordination and Outreach Center
🇺🇸NIH · United States
Funds the one centre that coordinates a rare-disease genomics programme and gets its protocols, data and tools out to everybody else.
GREGoRi Innovation Projects
NIH · United States
Funds a genuinely new experimental or computational approach to finding the cause of a rare genetic disorder, where the current state of the art falls short.
GREGoRi Technology Integration Center
🇺🇸NIH · United States
Funds the centre that turns new molecular methods for rare-disease diagnosis into standards, best practices and a benchmarking dataset.
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases
🇺🇸NIH · United States
Funds studies that watch patients rather than treat them, in bone, joint, rheumatic and skin disease. No intervention allowed.
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61)
🇺🇸NIH · United States
Funds early-stage clinical trials in arthritis, musculoskeletal and skin disease. A trial is compulsory.
Similar grants
Browse the directory →
Prevention and Intervention Approaches for FASD (R34)
🇺🇸NIAAA · United States
Supports FASD prevention and intervention planning studies to establish feasibility and practical research direction.
Prevention and Intervention Approaches for FASD (R61/R33)
🇺🇸NIAAA · United States
Supports translational research for FASD prevention and intervention, moving through feasibility and expansion milestones.
NCATS Preclinical Proof of Concept Studies for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies conducting preclinical efficacy studies to advance therapeutic candidates for rare diseases toward IND applications.
Pregnancy and Postpartum Hypertension Control Initiative (OWH) — Seed
🇺🇸HHS · United States
Supports maternal health and blood pressure monitoring initiatives for underserved pregnant and postpartum populations through community-linked innovation.
NHLBI Small Grant Program for K Recipients
🇺🇸NHLBI · United States
Supports former K awardees moving to independent NHLBI research through small grants.
Advancement and Innovation in Measurement of Language Development and Predictors
🇺🇸NIDCD · United States
Funds community-engaged language development measurement research for children under investigator-led initiatives in the United States.